These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 8321021)
1. Mutations within the FLR exon of NF1 are rare in myelodysplastic syndromes and acute myelocytic leukemias. Ludwig L; Janssen JW; Schulz AS; Bartram CR Leukemia; 1993 Jul; 7(7):1058-60. PubMed ID: 8321021 [TBL] [Abstract][Full Text] [Related]
2. Rare occurrence of mutations of the FLR exon of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Preudhomme C; Vachee A; Quesnel B; Wattel E; Cosson A; Fenaux P Leukemia; 1993 Jul; 7(7):1071. PubMed ID: 8321023 [No Abstract] [Full Text] [Related]
3. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia. Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106 [TBL] [Abstract][Full Text] [Related]
4. Analysis of mutations and expression of GAP-related domain of the neurofibromatosis type 1 (NF1) gene in the progression of chronic myelogenous leukemia. Nakai H; Misawa S; Horiike S; Taniwaki M; Seriu T; Shimazaki C; Fujii H; Maekawa T; Furukawa T; Abe T Leukemia; 1994 Jun; 8(6):1027-33. PubMed ID: 8207976 [TBL] [Abstract][Full Text] [Related]
5. Exon trap analysis of a NF1 splice-site mutation in a chronic myelomonocytic leukemia patient. Ludwig L; Janssen JW; Bartram CR Leukemia; 1995 May; 9(5):922-4. PubMed ID: 7769857 [TBL] [Abstract][Full Text] [Related]
6. Neurofibromatosis 1 gene (NF1) mutation is a rare genetic event in myelodysplastic syndrome regardless of the disease progression. Kaneko H; Horiike S; Nakai H; Ueda Y; Nakao M; Hirakawa K; Yokota S; Taniwaki M; Misawa S; Kashima K Int J Hematol; 1995 Apr; 61(3):113-6. PubMed ID: 7599322 [TBL] [Abstract][Full Text] [Related]
7. Absence of rearrangement of the neurofibromatosis 1 (NF1) gene in myelodysplastic syndromes and acute myeloid leukemia. Quesnel B; Preudhomme C; Vanrumbeke M; Vachee A; Lai JL; Fenaux P Leukemia; 1994 May; 8(5):878-80. PubMed ID: 8182944 [TBL] [Abstract][Full Text] [Related]
8. Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1. Maris JM; Wiersma SR; Mahgoub N; Thompson P; Geyer RJ; Hurwitz CG; Lange BJ; Shannon KM Cancer; 1997 Apr; 79(7):1438-46. PubMed ID: 9083167 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia. Lübbert M; Mirro J; Kitchingman G; McCormick F; Mertelsmann R; Herrmann F; Koeffler HP Oncogene; 1992 Feb; 7(2):263-8. PubMed ID: 1549347 [TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of bone marrow levels of neurofibromatosis-1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndrome. Lu D; Nounou R; Beran M; Estey E; Manshouri T; Kantarjian H; Keating MJ; Albitar M Cancer; 2003 Jan; 97(2):441-9. PubMed ID: 12518368 [TBL] [Abstract][Full Text] [Related]
11. [Flt-3/ITD mutation in pediatric leukemia and its clinical significance]. Wang J; Wang T; Li S; Lin L; Gang Y Ai Zheng; 2007 Jan; 26(1):58-63. PubMed ID: 17222369 [TBL] [Abstract][Full Text] [Related]
12. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis. Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P Leukemia; 1994 Aug; 8(8):1342-9. PubMed ID: 8057671 [TBL] [Abstract][Full Text] [Related]
13. Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells. MacGrogan D; Kalakonda N; Alvarez S; Scandura JM; Boccuni P; Johansson B; Nimer SD Genes Chromosomes Cancer; 2004 Nov; 41(3):203-13. PubMed ID: 15334543 [TBL] [Abstract][Full Text] [Related]
14. c-fms point mutations in acute myeloid leukemia: fact or fiction? Springall F; O'Mara S; Shounan Y; Todd A; Ford D; Iland H Leukemia; 1993 Jul; 7(7):978-85. PubMed ID: 8321048 [TBL] [Abstract][Full Text] [Related]
15. Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines. Yokota S; Kiyoi H; Nakao M; Iwai T; Misawa S; Okuda T; Sonoda Y; Abe T; Kahsima K; Matsuo Y; Naoe T Leukemia; 1997 Oct; 11(10):1605-9. PubMed ID: 9324277 [TBL] [Abstract][Full Text] [Related]
16. NF1 gene mutations in Japanese with neurofibromatosis 1 (NF1). Hatta N; Horiuchi T; Watanabe I; Kobayashi Y; Shirakata Y; Ohtsuka H; Minami T; Ueda K; Kokoroishi T; Fujita S Biochem Biophys Res Commun; 1995 Jul; 212(2):697-704. PubMed ID: 7542886 [TBL] [Abstract][Full Text] [Related]
17. Two NF1 mutations: frameshift in the GAP-related domain, and loss of two codons toward the 3' end of the gene. Abernathy CR; Colman SD; Kousseff BG; Wallace MR Hum Mutat; 1994; 3(4):347-52. PubMed ID: 8081387 [TBL] [Abstract][Full Text] [Related]
18. A heterozygous frameshift mutation in the Fanconi anemia C gene in familial T-ALL and secondary malignancy. Rischewski JR; Clausen H; Leber V; Niemeyer C; Ritter J; Schindler D; Schneppenheim R Klin Padiatr; 2000; 212(4):174-6. PubMed ID: 10994546 [TBL] [Abstract][Full Text] [Related]
19. Mutations of the PTPN11 gene in therapy-related MDS and AML with rare balanced chromosome translocations. Christiansen DH; Desta F; Andersen MK; Pedersen-Bjergaard J Genes Chromosomes Cancer; 2007 Jun; 46(6):517-21. PubMed ID: 17330262 [TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of neurofibromatosis type 1 mutations. Weiming X; Yu Q; Lizhi L; Ponder M; Wallace M; Gangfeng X; Ponder B Hum Mutat; 1992; 1(6):474-7. PubMed ID: 1301957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]